Investors and Media

Press Releases

October 31, 2024

Scholar Rock to Participate in Upcoming Investor Conferences

October 31, 2024

Scholar Rock to Present New Clinical and Biomarker Data from the Phase 1 DRAGON Trial at the SITC 39th Annual Meeting

October 22, 2024

Scholar Rock Announces Closing of Full Exercise of Option to Purchase Additional Shares in Public Offering

October 18, 2024

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 8, 2024

Scholar Rock Announces Pricing of Upsized $300 Million Public Offering of Common Stock and Pre-Funded Warrants

October 7, 2024

Scholar Rock Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

October 7, 2024

Scholar Rock Reports Apitegromab Meets Primary Endpoint in Phase 3 SAPPHIRE Study in Patients with Spinal Muscular Atrophy (SMA)

September 13, 2024

Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Archived Press Releases